Clinical Trial Update: LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids [Phase 3]

View source ↗

Summary

Phase 3 trial update on relugolix for heavy menstrual bleeding due to uterine fibroids completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding
• Uterine Fibroids

Drugs mentioned

• Relugolix (Relugolix)

Snippet

Sponsor: Myovant Sciences GmbH | Conditions: Heavy Menstrual Bleeding, Uterine Fibroid | Phase 3 | Status: COMPLETED | Results posted: 2022-04-19